Maynard Um
-
-
-
-
-
-
-
Beta Bionics, Inc. (BBNX) PT Lowered to $17 at Wolfe Research
-
-
-
-
-
-
-
UBS Starts Beta Bionics, Inc. (BBNX) at Buy
-
-
-
-
-
-
-
BofA Securities Downgrades Beta Bionics, Inc. (BBNX) to Neutral 'on new patient starts miss'
-
-
-
-
-
-
-
Goldman Sachs Upgrades Beta Bionics, Inc. (BBNX) to Buy
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Beta Bionics, Inc. (BBNX)
-
-
-
-
-
-
-
Piper Sandler Starts Beta Bionics, Inc. (BBNX) at Overweight
-
-
-
-
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

